Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment

Maria Ekholm

Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment

Maria Ekholm

Research output: Thesis › Doctoral Thesis (compilation)

1223 Downloads (Pure)

Original language	English
Qualification	Doctor
Awarding Institution	Department of Clinical Sciences, Lund
Supervisors/Advisors	Fernö, Mårten, Supervisor Ryden, Lisa, Supervisor Stål, Olle, Supervisor, External person
Award date	2018 Apr 20
Place of Publication	Lund
Publisher	Lund University: Faculty of Medicine
ISBN (Print)	978-91-7619-606-9
Publication status	Published - 2018

Bibliographical note

Defence details
Date: 2018-04-20
Time: 13:00
Place: The lecture hall in the Radiotherapy building, Klinikgatan 5, Skåne University Hospital, Lund, Sweden
External reviewer(s)
Name: Holmberg, Lars
Title: Professor emeritus
Affiliation: Faculty of Life Sciences and Medicine, King’s College, London, England and Department of Surgical Sciences, Uppsala University, Sweden
---
ISSN: 1652-8220
Lund University, Faculty of Medicine Doctoral Dissertation Series 2018:39

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Prognostic and Predictive Markers in Primary Breast Cancer_Maria EkholmFinal published version, 3.69 MB

3 Article

Two years of adjuvant tamoxifen provides a survival benefit compared with no systemic treatment in premenopausal patients with primary breast cancer: Long-Term follow-up (> 25 years) of the phase III SBII:2pre trial
Ekholm, M., Bendahl, P. O., Fernö, M., Nordenskjöld, B., Stål, O. & Rydén, L., 2016 Jul 1, In: Journal of Clinical Oncology. 34, 19, p. 2232-2238 7 p.
Research output: Contribution to journal › Article › peer-review
Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.
Ekholm, M., Grabau, D., Bendahl, P.-O., Bergh, J., Elmberger, G., Olsson, H., Russo, L., Viale, G. & Fernö, M., 2015, In: Acta Oncologica. 54, 7, p. 1040-1048
Research output: Contribution to journal › Article › peer-review
Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.
Ekholm, M., Beglerbegovic, S., Grabau, D., Lövgren, K., Malmström, P., Werner Hartman, L. & Fernö, M., 2014, In: Histopathology. 65, 2, p. 252-260
Research output: Contribution to journal › Article › peer-review

Cite this

@phdthesis{cf8b74966e084e1cbe0bb3c0155d29e6,

title = "Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment",

keywords = "Breast cancer, Quality assurance, Tamoxifen, Long-term effects",

author = "Maria Ekholm",

note = "Defence details Date: 2018-04-20 Time: 13:00 Place: The lecture hall in the Radiotherapy building, Klinikgatan 5, Sk{\aa}ne University Hospital, Lund, Sweden External reviewer(s) Name: Holmberg, Lars Title: Professor emeritus Affiliation: Faculty of Life Sciences and Medicine, King{\textquoteright}s College, London, England and Department of Surgical Sciences, Uppsala University, Sweden --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2018:39",

year = "2018",

language = "English",

isbn = "978-91-7619-606-9",

publisher = "Lund University: Faculty of Medicine",

type = "Doctoral Thesis (compilation)",

school = "Department of Clinical Sciences, Lund",

}

TY - THES

T1 - Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment

AU - Ekholm, Maria

N1 - Defence details Date: 2018-04-20 Time: 13:00 Place: The lecture hall in the Radiotherapy building, Klinikgatan 5, Skåne University Hospital, Lund, Sweden External reviewer(s) Name: Holmberg, Lars Title: Professor emeritus Affiliation: Faculty of Life Sciences and Medicine, King’s College, London, England and Department of Surgical Sciences, Uppsala University, Sweden --- ISSN: 1652-8220 Lund University, Faculty of Medicine Doctoral Dissertation Series 2018:39

PY - 2018

Y1 - 2018

KW - Breast cancer

KW - Quality assurance

KW - Tamoxifen

KW - Long-term effects

M3 - Doctoral Thesis (compilation)

SN - 978-91-7619-606-9

PB - Lund University: Faculty of Medicine

CY - Lund

ER -

Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment

Bibliographical note

Subject classification (UKÄ)

UN SDGs

Access to Document

Research output

Two years of adjuvant tamoxifen provides a survival benefit compared with no systemic treatment in premenopausal patients with primary breast cancer: Long-Term follow-up (> 25 years) of the phase III SBII:2pre trial

Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines - a Swedish survey with central re-assessment.

Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.

Cite this